Drugs Studies from the AAN

ProfG on CLAD and why he thinks it will come back

Clinical efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis (RRMS): final results from the 120-week phase IIIb extension trial to the CLARITY study (Poster 3.028). Authors: Gavin Giovannoni, Giancarlo Comi, Stuart Cook, Peter Rieckmann, Kottil Rammohan, Per Soelberg-Sorensen, Patrick Vermersch, E. Martin and Fernando Dangond

Some of you could not see the poster of the Alemtuzumab 10 year data so listen to Mario Habek give an info burst. 

Finally we have Prof Mark Freedman talking Aubagio.

Final Outcomes of the Teriflunomide Phase 2 Extension Study: 13 Years of Efficacy and Safety Results (Poster 3.027). Authors: Marcelo Kremenchutzky, Mark S Freedman, Amit Bar-Or, Annie Purvis, Myriam Benamor, Philippe Truffinet, and Paul W O’Connor

Prof Freedman will be back soon and has done a Guest Post on his soon to be published research. I can't wait.

CoI: None

Labels: , ,